IV BUSULFAN-BASED REDUCED INTENSITY REGIMEN (RIC) BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IS WELL TOLERATE AND EFFECTIVE IN PATIENTS WITH HEMATOLOGICAL DISEASES

被引：0
|
作者：
Castagna, L. [1 ]
Furst, S. [1 ]
El-Cheikh, J. [1 ]
Faucher, C. [1 ]
Vey, N. [1 ]
Bouabdallah, R. [1 ]
Stoppa, A. -M [1 ]
Mohty, M. [2 ]
Chabannon, C. [1 ]
Esterni, B. [1 ]
Blaise, D. [1 ]
机构：
[1] Inst Paoli Calmettes, Marseille, France
[2] CHU Hotel Dieu, Nantes, France
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
373
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [1] Busulfan-based reduced-intensity regimen before allogeneic stem cell transplantation is well-tolerated and effective in patients with haematological diseases
    Castagna, L.
    Fuerst, S.
    El Cheikh, J.
    Faucher, C.
    Vey, N.
    Bouabdallah, R.
    Stoppa, A.
    Mohty, M.
    Chabannon, C.
    Esterni, B.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S288 - S288
  • [2] Busulfan-based reduced-intensity regimen before allogeneic stem cell transplantation: tolerance of three days intravenous and fractionated busulfan
    Reman, O.
    Chantepie, S. P.
    Gac, A. C.
    Marin, E.
    Moreno, V.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S295 - S295
  • [3] BUSULFAN-BASED REDUCED INTENSITY CONDITIONING REGIMEN (RIC) FOR LYMPHOID MALIGNANCIES
    Sekhar, J.
    Stockerl-Goldstein, K.
    Cashen, A.
    Zhang, Q.
    Witowski, S.
    Abboud, C.
    Uy, G.
    Westervelt, P.
    Dipersio, J.
    Vij, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S283 - S283
  • [4] Renal Complications after Busulfan-Based Reduced-Intensity Stem Cell Transplantation in 286 Patients with Hematological Disorders
    Yakushijin, Kimikazu
    Fukuda, Takahiro
    Asakura, Yoshitaka
    Kurosawa, Saiko
    Hiramoto, Nobuhiro
    Nakamura, Daisuke
    Tada, Kohei
    Nishinohara, Masaaki
    Hagiwara, Akihito
    Ueno, Niina
    Kamiyama, Yutaro
    Mori, Masakazu
    Kim, Sung-Won
    Mori, Shin-ichiro
    Tanosaki, Ryuji
    Heike, Yuji
    Takaue, Yoichi
    BLOOD, 2009, 114 (22) : 1301 - 1302
  • [5] Fludarabine phosphete and melphalan - An immunosuppressive reduced intensity conditioning (RIC) regimen for allogeneic stem cell transplantation in patients with a range of hematological malignancies
    Jackson, G
    Richardson, C
    Morgan, G
    Smith, G
    Johnson, P
    Davies, J
    Burnett, A
    Poynton, C
    Wilson, K
    Wareham, E
    Stars, A
    Tollerfield, S
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 15 - 18
  • [6] Fludarabine phosphate and melphalan - an immunosuppressive reduced intensity conditioning (RIC) regimen for allogeneic stem cell transplantation in patients with a range of hematological malignancies
    Jackson, G
    Richardson, C
    Morgan, G
    Smith, G
    Johnson, P
    Davies, J
    Burnett, A
    Poynton, C
    Wilson, K
    Wareham, E
    Stars, A
    Tollerfield, S
    BONE MARROW TRANSPLANTATION, 2002, 29 : S157 - S158
  • [7] Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen
    Parta, Mark
    Shah, Nirali N.
    Baird, Kristin
    Rafei, Hind
    Calvo, Katherine R.
    Hughes, Thomas
    Cole, Kristen
    Kenyon, Meg
    Schuver, Bazetta Blacklock
    Cuellar-Rodriguez, Jennifer
    Zerbe, Christa S.
    Holland, Steven M.
    Hickstein, Dennis D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (06) : 1250 - 1259
  • [8] Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies
    Valcárcel, D
    Martino, R
    Sureda, A
    Canals, C
    Altés, A
    Briones, J
    Sanz, MA
    Parody, R
    Constans, M
    Villela, SL
    Brunet, S
    Sierra, J
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (02) : 144 - 151
  • [9] Allogeneic Stem-Cell Transplantation for AML and MDS with Tresosulfan Compared with Busulfan-Based Regimens; Reduced Toxicity Vs. Reduced Intensity
    Shimoni, Avichai
    Shem-Tov, Noga
    Danylesko, Ivetta
    Volchek, Yulia
    Yerushalmi, Ronit
    Nagler, Arnon
    BLOOD, 2011, 118 (21) : 231 - 231
  • [10] Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen
    Holland, Steven M.
    Baird, Kristin
    Parta, Mark
    Rafei, Hind
    Shah, Nirali N.
    Cole, Kristen
    BLOOD, 2017, 130
12345